E-Migra: My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring

Sponsor
Unidade Local de Saúde de Matosinhos, EPE (Other)
Overall Status
Recruiting
CT.gov ID
NCT04828941
Collaborator
(none)
60
1
2
7.2
8.4

Study Details

Study Description

Brief Summary

This study aims to evaluate the usefulness of an app-based headache diary in episodic migraine patients. For this the investigators will conduct a randomized clinical trial with a crossover design, using the app-based diary and a traditional paper-based headache diary. The patients will use each diary for 13 weeks. The investigators will evaluate diary adhesion after each 13-week period, and also evaluate headache burden and prophylactic medication compliance at the beginning, at the crossover point, and at the end of the study, and acute headache medication use through diary records. The investigators will also evaluate user preference through a questionnaire at the end of the study.

Condition or Disease Intervention/Treatment Phase
  • Device: Electronic Headache Diary
  • Device: Paper Diary
N/A

Detailed Description

Headache is one of the main reasons for seeking primary health care and an important cause of absenteeism at work and decreased quality of life in the population, being the major neurological cause of disability in young adults and middle-aged adults. Although the subjectivity of the complaints and the great intra and inter-individual variability of clinical presentations hinder its epidemiological study, it is estimated that the overall prevalence of headache throughout life is 66% (46-78% in tension-type headache; 14-16% for migraine and 0.1-0.3% for cluster headache). Migraine, in particular, is a primary headache with an estimated prevalence of 11 to 14% in adult women and 4 to 9% in adult men. In addition, it is assumed that up to 20% of absences from work can be attributed to headaches, with the inherent socio-economic impacts.

Headache is a very frequent complaint in the primary care setting. However, the differential diagnosis can be complicated at this level. Primary headache diagnosis is made almost exclusively through clinical history taking, for this purpose clinicians use the criteria in the International Classification of Headache Disorders, currently on its 3rd version. However, its application is often challenging and time-consuming, especially in a primary care setting, where physicians are very limited on time. Nonetheless, a correct diagnosis is essential, as treatment varies among the primary headaches and also within the same headache type according to its frequency.

The episodic nature of headaches increases the risk of memory bias towards more severe or more recent crises. To avoid this, patients nowadays use a paper calendar. This calendar makes it possible to monitor, more reliably, the response to therapy and to identify the need for any adjustments.

However, the paper calendar has many limitations, such as the possibility of filling in immediately before consultations instead of non-biased daily records. In addition, the paper or card used can be lost, is more easily forgotten, and cannot be consulted remotely by the attending physician. In the current digital landscape, we have seen a transition in registration methods for semi-automated electronic platforms, considered more practical and appealing to users. However, most in-app headache diaries are not validated and are mainly written in English.

Having these ideas in mind the investigators decided to develop an app-based electronic headache diary that would not only permit a better adhesion to follow-up but also remote monitoring of headache patients. To study the applicability and the usefulness of this idea the investigators designed a randomized clinical trial with a crossover design where episodic migraine patients would be randomized to the use of the app or of a paper headache diary. Each patient would use the app and the paper diary for a period of 13 weeks.

In the paper and electronic diary patients will record headache days, headache type (migraine or tension-type headache), headache intensity with a scale from 0 to 10, intake of acute headache medication, missing work days due to headache, and recurrence to the emergency department due to headache.

The investigators will also measure headache burden with the portuguese versions of HIT-6, MSQ v2.1 and MiDAS scales and quality of life with the WHOQOL-BREF at the beginning, at the crossover point, and at the end of the study. Also, the study will evaluate prophylactic medication compliance at the beginning, at the crossover point, and at the end of the study through a questionnaire. User preference will be measured through a questionnaire, using a Likert type scale, at the end of the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Each patient will use the electronic headache diary and the paper diary for a period of 13 weeks, the order of their use will be determined by randomisation.Each patient will use the electronic headache diary and the paper diary for a period of 13 weeks, the order of their use will be determined by randomisation.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
A 26-week Randomized Clinical Trial of an Electronic Headache Diary in Migraine Patients
Anticipated Study Start Date :
Mar 28, 2021
Anticipated Primary Completion Date :
Oct 2, 2021
Anticipated Study Completion Date :
Nov 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Electronic Headache Diary

The electronic headache diary registers: total number of days with headache per month, number of days with migraine per month, number of days with tension headache per month, number of days taking SOS medication per month, number of days with incapacity for work per month, number of days in which patient goes to the emergency department.

Device: Electronic Headache Diary
The electronic headache diary is an app-based diary that permits the registration of headaches, their acute treatment and their associated work incapacity. It also permits real-time monitoring of these data.

Active Comparator: Paper Diary

The paper headache diary registers: total number of days with headache per month, number of days with migraine per month, number of days with tension headache per month, number of days taking SOS medication per month, number of days with incapacity for work per month, number of days in which patient goes to the emergency department.

Device: Paper Diary
The paper diary permits the registration of the same variables as the electronic diary in paper format.

Outcome Measures

Primary Outcome Measures

  1. Diary compliance [6 months]

    To assess whether the compliance of migraine patients to the use of an electronic headache diary is superior to adherence to the paper diary. The quantification of adherence will be made in: 1.1.) % Of days per month of headache registration; and 1.2.) % of patients who abandon calendar registration at 13 weeks.

Secondary Outcome Measures

  1. Patient Preference [6 months]

    Preference of the patient for one of the diaries measured through a questionnaire.

  2. Quality of Life (HIT-6) [6 months]

    Comparison of the quality of life using data from HIT-6 evaluated at the baseline, after using the electronic diary and after using the paper diary.

  3. Quality of Life (MSQ v2.1) [6 months]

    Comparison of the quality of life using data from MSQ v2.1 evaluated at the baseline, after using the electronic diary and after using the paper diary.

  4. Quality of Life (WHOQOL-BREF) [6 months]

    Comparison of the quality of life using data from WHOQOL-BREF evaluated at the baseline, after using the electronic diary and after using the paper diary.

  5. Incapacity Days [6 months]

    Comparison of the number of incapacity days using data from the diaries and from MiDAS evaluated at the baseline, after using the electronic diary and after using the paper diary.

  6. Subjective Evaluation of the Number of Headache Days [6 months]

    Comparison of the patient's subjective evaluation of the number of headache days using data from questionnaires evaluated at the baseline, after using the electronic diary and after using the paper diary.

  7. Number of Acute Headache Medication Use Days [6 months]

    Comparison of the number of acute headache medication use days using data from the diaries and questionnaires filled at the baseline, after using the electronic diary and after using the paper diary.

  8. Prophylactic Medication Compliance [6 months]

    Comparison of the number of days of prophylactic medication noncompliance evaluated by questionnaire at the baseline, after using the electronic diary and after using the paper diary.

  9. Emergency Department Visits [6 months]

    Comparison of the number of emergency department visits evaluated by data collected from the diaries and a questionnaire filled at the baseline, after using the electronic diary and after using the paper diary.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with episodic migraine, diagnosed for more than 6 months.

  • Patients with at least 4 headache days per month and a maximum of 15 headache days per month.

Exclusion Criteria:
  • Patients with major psychiatric illness.

  • Patients participating in another clinical trial.

  • Patients who do not meet diagnostic criteria for episodic migraine according to ICHD-3.

  • Illiterate patients or those who are unable to fill the records independently.

  • Patients with a previous history of filling in a headache calendar, in the 3 months prior to randomization.

  • Patients who do not use a cell phone with Android OS.

  • Patients who cannot read or write in Portuguese.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos Matosinhos Porto Portugal 4464-513

Sponsors and Collaborators

  • Unidade Local de Saúde de Matosinhos, EPE

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Axel Ferreira, MD, PhDs, Unidade Local de Saúde de Matosinhos, EPE
ClinicalTrials.gov Identifier:
NCT04828941
Other Study ID Numbers:
  • 96/CE/JAS
First Posted:
Apr 2, 2021
Last Update Posted:
Apr 2, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Axel Ferreira, MD, PhDs, Unidade Local de Saúde de Matosinhos, EPE
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 2, 2021